Mark Cuban discusses his approach to fixing healthcare, emphasizing transparency in drug pricing and the need to dismantle the influence of pharmacy benefit managers. He advocates for cash pricing legislation and supports the Break Up Big Medicine Act to separate insurance companies from their non-insurance interests.

• The Dallas Mavericks paid $169,000 for generic drugs that would have cost just $19,000 through Cuban's Cost Plus company.
• Cuban backs the Break Up Big Medicine Act, which would force insurance companies to divest their PBM arms.
• He wants legislation requiring cash drug payments to count toward insurance deductibles, plus state-controlled formularies to curb PBM power.
• He gave TrumpRx an "A-" and says FDA application costs, not tariffs, are the real barrier to bringing generic manufacturing to the US.